{
    "id": 28289,
    "fullName": "EGFR P794L",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EGFR P794L lies within the protein kinase domain of the Egfr protein (UniProt.org). P794L has been associated with resistance to Tagrisso (osimertinib) in a patient (PMID: 29704676), but has not been biochemically characterized and therefore, its effect on Egfr protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 11378,
                    "pubMedId": 29704676,
                    "title": "Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29704676"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "P794L",
    "createDate": "05/31/2018",
    "updateDate": "10/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 176009,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181390C>T",
        "cDna": "c.2381C>T",
        "protein": "p.P794L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13953,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tagrisso (osimertinib) treatment resulted in initial response in a patient with non-small cell lung carcinoma harboring an EGFR exon 19 deletion (E746_S752del) and T790M, however, the disease progressed 20 months after treatment started, and EGFR P794L was identified by liquid biopsy at the time of progression (PMID: 29704676).",
            "molecularProfile": {
                "id": 29894,
                "profileName": "EGFR E746_S752del EGFR T790M EGFR P794L"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 11378,
                    "pubMedId": 29704676,
                    "title": "Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29704676"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13954,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Gilotrif (afatinib) treatment resulted in rapid clinical response in a patient with non-small cell lung carcinoma harboring an EGFR exon 19 deletion (E746_S752del), EGFR T790M and EGFR P794L (PMID: 29704676).",
            "molecularProfile": {
                "id": 29894,
                "profileName": "EGFR E746_S752del EGFR T790M EGFR P794L"
            },
            "therapy": {
                "id": 623,
                "therapyName": "Afatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11378,
                    "pubMedId": 29704676,
                    "title": "Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29704676"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29893,
            "profileName": "EGFR P794L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29894,
            "profileName": "EGFR E746_S752del EGFR T790M EGFR P794L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 176009,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181390C>T",
            "cDna": "c.2381C>T",
            "protein": "p.P794L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}